Report Overview
Report Summary
Risedronate is in a class of drugs called bisphosphonates used for the treatment of Paget's disease of bone (in which the formation of bone is abnormal) and in persons with osteoporosis (in which the density and strength of bones are reduced).
The global Risedronate market is valued at xx million US$ in 2020 and will reach xx million US$ by the end of 2027, growing at a CAGR of xx% during 2021-2027. The objectives of this study are to define, segment, and project the size of the Risedronate market based on company, product type, end user and key regions.
This report studies the global market size of Risedronate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Risedronate in these regions.
This research report categorizes the global Risedronate market by top players/brands, region, type and end user. This report also studies the global Risedronate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
Amgen
Teva
Mylan
Apotex
Sanofi
Abbott
Novartis
Tecoland
Taj Pharmaceuticals
Market size by Product
5 mg Tablets
35 mg Tablets
75 mg Tablets
150 mg Tablets
Market size by End User
Postmenopausal Osteoporosis
Men with Osteoporosis
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Risedronate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Risedronate market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Risedronate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Risedronate submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Risedronate are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Risedronate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Risedronate Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Risedronate Market Size Growth Rate by Product
1.4.2 5 mg Tablets
1.4.3 35 mg Tablets
1.4.4 75 mg Tablets
1.4.5 150 mg Tablets
1.5 Market by End User
1.5.1 Global Risedronate Market Size Growth Rate by End User
1.5.2 Postmenopausal Osteoporosis
1.5.3 Men with Osteoporosis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Risedronate Market Size
2.1.1 Global Risedronate Revenue 2017-2027
2.1.2 Global Risedronate Sales 2017-2027
2.2 Risedronate Growth Rate by Regions
2.2.1 Global Risedronate Sales by Regions
2.2.2 Global Risedronate Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Risedronate Sales by Manufacturers
3.1.1 Risedronate Sales by Manufacturers
3.1.2 Risedronate Sales Market Share by Manufacturers
3.1.3 Global Risedronate Market Concentration Ratio (CR5 and HHI)
3.2 Risedronate Revenue by Manufacturers
3.2.1 Risedronate Revenue by Manufacturers (2017-2020)
3.2.2 Risedronate Revenue Share by Manufacturers (2017-2020)
3.3 Risedronate Price by Manufacturers
3.4 Risedronate Manufacturing Base Distribution, Product Types
3.4.1 Risedronate Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Risedronate Product Type
3.4.3 Date of International Manufacturers Enter into Risedronate Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Risedronate Sales by Product
4.2 Global Risedronate Revenue by Product
4.3 Risedronate Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Risedronate Breakdown Data by End User
6 North America
6.1 North America Risedronate by Countries
6.1.1 North America Risedronate Sales by Countries
6.1.2 North America Risedronate Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Risedronate by Product
6.3 North America Risedronate by End User
7 Europe
7.1 Europe Risedronate by Countries
7.1.1 Europe Risedronate Sales by Countries
7.1.2 Europe Risedronate Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Risedronate by Product
7.3 Europe Risedronate by End User
8 Asia Pacific
8.1 Asia Pacific Risedronate by Countries
8.1.1 Asia Pacific Risedronate Sales by Countries
8.1.2 Asia Pacific Risedronate Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Risedronate by Product
8.3 Asia Pacific Risedronate by End User
9 Central & South America
9.1 Central & South America Risedronate by Countries
9.1.1 Central & South America Risedronate Sales by Countries
9.1.2 Central & South America Risedronate Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Risedronate by Product
9.3 Central & South America Risedronate by End User
10 Middle East and Africa
10.1 Middle East and Africa Risedronate by Countries
10.1.1 Middle East and Africa Risedronate Sales by Countries
10.1.2 Middle East and Africa Risedronate Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Risedronate by Product
10.3 Middle East and Africa Risedronate by End User
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Business Overview
11.1.3 Merck Risedronate Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Merck Risedronate Products Offered
11.1.5 Merck Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Company Business Overview
11.2.3 Amgen Risedronate Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Amgen Risedronate Products Offered
11.2.5 Amgen Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Company Business Overview
11.3.3 Teva Risedronate Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Teva Risedronate Products Offered
11.3.5 Teva Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Company Business Overview
11.4.3 Mylan Risedronate Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Mylan Risedronate Products Offered
11.4.5 Mylan Recent Development
11.5 Apotex
11.5.1 Apotex Company Details
11.5.2 Company Business Overview
11.5.3 Apotex Risedronate Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Apotex Risedronate Products Offered
11.5.5 Apotex Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Company Business Overview
11.6.3 Sanofi Risedronate Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Sanofi Risedronate Products Offered
11.6.5 Sanofi Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Company Business Overview
11.7.3 Abbott Risedronate Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Abbott Risedronate Products Offered
11.7.5 Abbott Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Company Business Overview
11.8.3 Novartis Risedronate Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Novartis Risedronate Products Offered
11.8.5 Novartis Recent Development
11.9 Tecoland
11.9.1 Tecoland Company Details
11.9.2 Company Business Overview
11.9.3 Tecoland Risedronate Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Tecoland Risedronate Products Offered
11.9.5 Tecoland Recent Development
11.10 Taj Pharmaceuticals
11.10.1 Taj Pharmaceuticals Company Details
11.10.2 Company Business Overview
11.10.3 Taj Pharmaceuticals Risedronate Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Taj Pharmaceuticals Risedronate Products Offered
11.10.5 Taj Pharmaceuticals Recent Development
12 Future Forecast
12.1 Risedronate Market Forecast by Regions
12.1.1 Global Risedronate Sales Forecast by Regions 2021-2027
12.1.2 Global Risedronate Revenue Forecast by Regions 2021-2027
12.2 Risedronate Market Forecast by Product
12.2.1 Global Risedronate Sales Forecast by Product 2021-2027
12.2.2 Global Risedronate Revenue Forecast by Product 2021-2027
12.3 Risedronate Market Forecast by End User
12.4 North America Risedronate Forecast
12.5 Europe Risedronate Forecast
12.6 Asia Pacific Risedronate Forecast
12.7 Central & South America Risedronate Forecast
12.8 Middle East and Africa Risedronate Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Risedronate Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer